Dr. Nakano is a Professor in the Department of Rheumatology at Kawasaki Medical School, Japan. He specializes in the treatment of rheumatoid arthritis, systemic lupus erythematosus, and other autoimmune diseases. His research focuses on the impact of epigenetic abnormalities on synovial changes in rheumatoid arthritis and excessive fibrosis in systemic sclerosis. As a principal investigator, he has led numerous clinical trials, contributing to the advancement of novel therapeutic strategies. Dr. Nakano has received several awards at international conferences in recognition of his research contributions. With extensive experience in both clinical practice and translational research, he remains dedicated to improving patient outcomes through innovative approaches.